Early assessment of cardiovascular toxicity of pertuzumab
plustrastuzumab plus docetaxel for HER-2 positive metastatic
breastcancer (MBC) in pretreated patients with trastuzumab in the
neo/adjuvant setting
Early assessment of cardiovascular toxicity of pertuzumab plustrastuzumab plus docetaxel for HER-2 positive metastatic breastcancer (MBC) in pretreated patients with trastuzumab in the neo/adjuvant setting
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2019
Συγγραφείς:
Michalaki, V. Kontis, I. Koutroulis, G. Karvouni, E. and Papadimitriou, C.
